Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lirametostat in B-Cell Lymphomas
NCT02395601Phase 1Completed
- Sponsor
- Constellation Pharmaceuticals
- Start
- Mar 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lirametostat in B cell lymphoma, sponsored by Constellation Pharmaceuticals. Primary endpoint: Frequency of Dose-limiting toxicities. Started Mar 2015; status: completed.
02
Drugs
lirametostat
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT02395601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395601.